Circulating acute phase cytokines and cytokine inhibitors in fluminant hepatic failure: Associations with mortality and haemodynamics

Clinical Intensive Care

Volumn 12, Issue 3, 2001, Pages 127-134

  Sheron, N ^a   Keana, H ^a   Goka, J ^a   Alexander, G ^a   Williams, R ^a   Wendon, J ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; CYTOKINE; ENDOTOXIN; INHIBITOR PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; OXYGEN; PROTEIN P55; PROTEIN P75; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ACIDOSIS; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CIRCULATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTOXEMIA; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INFLAMMATION; INTENSIVE CARE UNIT; LIVER FAILURE; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; MEDIATOR; MEDICAL ASSESSMENT; MEDICAL PARAMETERS; MORTALITY; MULTIPLE ORGAN FAILURE; OXYGEN CONSUMPTION; PATIENT REFERRAL; PROSPECTIVE STUDY; SEPTIC SHOCK; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE; TEACHING HOSPITAL; UNITED KINGDOM;

EID: 0034920439     PISSN: 09563075     EISSN: None     Source Type: Journal    
DOI: 10.3109/tcic.12.3.127.134     Document Type: Article

References (40)

1. Effects of vasopressor agents and epoprostenol on systemic hemodynamics and oxygen transport in fulminant hepatic failure
2. Induction of tumor necrosis factor, IFN-gamma, and acute lethality in mice by toxic and non-toxic forms of lipid A
3. Fungal infection: A common, unrecognised complication of acute liver failure
4. Prospective study of bacterial infection in acute liver failure: An analysis of fifty patients
5. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure
6. Tumour necrosis factor production in fulminant hepatic failure: Relation to aetiology and superimposed microbial infection
7. Increased plasma tumor necrosis factor in severe alcoholic hepatitis
8. Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis
9. Serum levels of cytokines in chronic liver diseases
10. The management of fulminant hepatic failure
11. Cachectin, cachexia, and shock
12. Two types of septic shock classified by the plasma levels of cytokines and endotoxin
13. The cytokine network in the critically ill
14. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin
15. Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia
16. Interleukin-6 and interleukin-8 concentrations as predictors of outcome in ventricular assist device patients before heart transplantation
17. Interleukin-6 and interleukin-8 in serum and urine in patients with acute pyelonephritis in relation to bacterial-virulence-associated traits and renal function
18. Properties of the novel proinflammatory supergene intercrine cytokine family
19. Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation
20. Alterations of neutrophil responses to tumor necrosis factor alpha and interleukin-8 following human endotoxemia
21. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure
22. Interleukin-8 serum concentrations after liver transplantation
23. Cytokines in alcoholic liver cirrhosis
24. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration
25. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: The effect of antiinflammatory agents
26. Endotoxin and tumor necrosis factor-alpha-induced interleukin-8 release in humans
27. IL-8 in septic shock, endotoxemia, and after IL-1 administration
28. Comparison of reactivity of monoclonal antibody (3F2) to trimeric tumor necrosis factor (TNF-alpha) with that to monomeric TNF-alpha
29. Interleukin-6 is necessary, but not sufficient, for induction of the human C-reactive protein gene in vivo
30. Immunochemical characterisation of megakaryocyte potentiator activity from mouse bone marrow
31. Increased plasma levels of interleukin-6 in sepsis
32. Systemic inflammatory response syndrome after cardiac operations
33. A phase I trial of intravenous interleukin-6 in patients with advanced cancer
34. Long-term consequences of interleukin-6 overexpression in transgenic mice
35. Response of interleukin-6-deficient mice to tumor necrosis factor-induced metabolic changes and lethality
36. Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection
37. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice
38. The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans
39. Continuous venovenous hemofiltration with dialysis in combination with total hepatectomy and portocaval shunting. Bridge to liver transplantation
40. Total hepatectomy and liver transplantation as two-stage procedure